Myocardial Scar and Fibrosis: The Ultimate Mediator of Outcomes?

Area of Science:

• Cardiology
• Pathology
• Biomedical Engineering

Background:

• The precise origins of complex myocardial pathology leading to heart failure remain poorly understood.
• Myocardial fibrosis is increasingly recognized as a significant factor in heart failure progression and outcomes.
• Existing literature highlights the detrimental impact of excess interstitial protein, as seen in cardiac amyloidosis, on heart function.

Purpose of the Study:

• To address the lack of a standardized taxonomy for prioritizing the causes of heart failure.
• To investigate the definitive role of myocardial fibrosis as a principal pathway in mediating heart failure outcomes.
• To leverage new quantification methods to establish the link between fibrosis and heart failure vulnerability.

Main Methods:

• Review of existing literature on heart failure pathophysiology and myocardial fibrosis.
• Analysis of studies employing robust methods for quantifying myocardial fibrosis.
• Case study analysis, such as cardiac amyloidosis, to illustrate protein deposition and its effects.

Main Results:

• Myocardial fibrosis is consistently implicated as a major pathway in heart failure.
• Cardiac amyloidosis serves as a clear example of interstitial protein overload leading to severe heart failure.
• Current robust methods enable precise quantification of myocardial fibrosis.

Conclusions:

• Establishing a clear taxonomy for heart failure origins is crucial for advancing research.
• Myocardial fibrosis is unequivocally a principal pathway mediating heart failure outcomes.
• Quantifiable myocardial fibrosis is key to understanding heart failure vulnerability.